APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Plant-based Cannabidiol (CBD) Nutraceuticals

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Plant-based Cannabidiol (CBD) Nutraceuticals Market Outlook and Growth Opportunities 2026

Report ID 174026230420 December 2025198 pages

Choose your research edition.

Industry ResearchPlant-based Cannabidiol (CBD) Nutraceuticals Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Plant-based Cannabidiol (CBD) Nutraceuticals Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Plant-based Cannabidiol (CBD) Nutraceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plant-based Cannabidiol (CBD) Nutraceuticals Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Plant-based Cannabidiol (CBD) Nutraceuticals Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Plant-based Cannabidiol (CBD) Nutraceuticals market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Plant-based Cannabidiol (CBD) Nutraceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Plant-based Cannabidiol (CBD) Nutraceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plant-based Cannabidiol (CBD) Nutraceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Plant-based Cannabidiol (CBD) Nutraceuticals market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Plant-based Cannabidiol (CBD) Nutraceuticals market include Medical Marijuana, Inc, Isodiol, Irwin Naturals, Green Roads, Garden of Life, Foria Wellness, Diamond CBD and CV Sciences, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Plant-based Cannabidiol (CBD) Nutraceuticals market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Plant-based Cannabidiol (CBD) Nutraceuticals and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Plant-based Cannabidiol (CBD) Nutraceuticals sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Plant-based Cannabidiol (CBD) Nutraceuticals market size, projected growth trends, production technologies, key applications, and end-use industries.

Plant-based Cannabidiol (CBD) Nutraceuticals Segment by Company

Medical Marijuana, Inc

Isodiol

Irwin Naturals

Green Roads

Garden of Life

Foria Wellness

Diamond CBD

CV Sciences, Inc.

Plant-based Cannabidiol (CBD) Nutraceuticals Segment by Type

Capsules & Softgels

CBD Gummies

CBD Tinctures

Others

Plant-based Cannabidiol (CBD) Nutraceuticals Segment by Application

Retail Stores

Online Sales

Pharmacies

Plant-based Cannabidiol (CBD) Nutraceuticals Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Plant-based Cannabidiol (CBD) Nutraceuticals status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Plant-based Cannabidiol (CBD) Nutraceuticals market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Plant-based Cannabidiol (CBD) Nutraceuticals significant trends, drivers, influence factors in global and regions.

6. To analyze Plant-based Cannabidiol (CBD) Nutraceuticals competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plant-based Cannabidiol (CBD) Nutraceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plant-based Cannabidiol (CBD) Nutraceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plant-based Cannabidiol (CBD) Nutraceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Plant-based Cannabidiol (CBD) Nutraceuticals market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plant-based Cannabidiol (CBD) Nutraceuticals industry.

Chapter 3: Detailed analysis of Plant-based Cannabidiol (CBD) Nutraceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Plant-based Cannabidiol (CBD) Nutraceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Plant-based Cannabidiol (CBD) Nutraceuticals in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Plant-based Cannabidiol (CBD) Nutraceuticals Industry Trends Table 2. Plant-based Cannabidiol (CBD) Nutraceuticals Industry Drivers Table 3. Plant-based Cannabidiol (CBD) Nutraceuticals Industry Opportunities and Challenges Table 4. Plant-based Cannabidiol (CBD) Nutraceuticals Industry Restraints Table 5. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue Share by Company (2021-2026) Table 7. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume Share by Company (2021-2026) Table 9. Global Plant-based Cannabidiol (CBD) Nutraceuticals Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Plant-based Cannabidiol (CBD) Nutraceuticals Company Ranking, (2024-2026) & (USD Million) Table 11. Global Plant-based Cannabidiol (CBD) Nutraceuticals Key Company Manufacturing Base & Headquarters Table 12. Global Plant-based Cannabidiol (CBD) Nutraceuticals Company, Product Type & Application Table 13. Global Plant-based Cannabidiol (CBD) Nutraceuticals Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Plant-based Cannabidiol (CBD) Nutraceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Capsules & Softgels Table 18. Significant Companies of CBD Gummies Table 19. Significant Companies of CBD Tinctures Table 20. Significant Companies of Others Table 21. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume Share by Type (2021-2026) Table 25. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume Share by Type (2027-2032) Table 26. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type (2021-2026) Table 30. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Retail Stores Table 32. Significant Companies of Online Sales Table 33. Significant Companies of Pharmacies Table 34. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume Share by Application (2021-2026) Table 38. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume Share by Application (2027-2032) Table 39. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application (2021-2026) Table 43. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application (2027-2032) Table 44. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Region (2021-2026) & (K Units) Table 46. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Region (2021-2026) Table 47. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Region (2027-2032) & (K Units) Table 48. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Region (2027-2032) Table 49. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Region (2021-2026) Table 52. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Region (2027-2032) Table 54. Global Plant-based Cannabidiol (CBD) Nutraceuticals Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Plant-based Cannabidiol (CBD) Nutraceuticals Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2021-2026) & (K Units) Table 59. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Country (2021-2026) Table 60. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2027-2032) & (K Units) Table 61. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Country (2027-2032) Table 62. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Market Share by Country (2021-2026) Table 64. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Market Share by Country (2027-2032) Table 66. Medical Marijuana, Inc Company Information Table 67. Medical Marijuana, Inc Business Overview Table 68. Medical Marijuana, Inc Plant-based Cannabidiol (CBD) Nutraceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Medical Marijuana, Inc Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio Table 70. Medical Marijuana, Inc Recent Development Table 71. Isodiol Company Information Table 72. Isodiol Business Overview Table 73. Isodiol Plant-based Cannabidiol (CBD) Nutraceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Isodiol Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio Table 75. Isodiol Recent Development Table 76. Irwin Naturals Company Information Table 77. Irwin Naturals Business Overview Table 78. Irwin Naturals Plant-based Cannabidiol (CBD) Nutraceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Irwin Naturals Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio Table 80. Irwin Naturals Recent Development Table 81. Green Roads Company Information Table 82. Green Roads Business Overview Table 83. Green Roads Plant-based Cannabidiol (CBD) Nutraceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Green Roads Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio Table 85. Green Roads Recent Development Table 86. Garden of Life Company Information Table 87. Garden of Life Business Overview Table 88. Garden of Life Plant-based Cannabidiol (CBD) Nutraceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Garden of Life Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio Table 90. Garden of Life Recent Development Table 91. Foria Wellness Company Information Table 92. Foria Wellness Business Overview Table 93. Foria Wellness Plant-based Cannabidiol (CBD) Nutraceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Foria Wellness Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio Table 95. Foria Wellness Recent Development Table 96. Diamond CBD Company Information Table 97. Diamond CBD Business Overview Table 98. Diamond CBD Plant-based Cannabidiol (CBD) Nutraceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Diamond CBD Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio Table 100. Diamond CBD Recent Development Table 101. CV Sciences, Inc. Company Information Table 102. CV Sciences, Inc. Business Overview Table 103. CV Sciences, Inc. Plant-based Cannabidiol (CBD) Nutraceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. CV Sciences, Inc. Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio Table 105. CV Sciences, Inc. Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Plant-based Cannabidiol (CBD) Nutraceuticals Distributors List Table 109. Plant-based Cannabidiol (CBD) Nutraceuticals Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Plant-based Cannabidiol (CBD) Nutraceuticals Product Image Figure 2. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value (2021-2032) & (US$ Million) Figure 4. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales (2021-2032) & (K Units) Figure 5. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Plant-based Cannabidiol (CBD) Nutraceuticals Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Capsules & Softgels Image Figure 10. CBD Gummies Image Figure 11. CBD Tinctures Image Figure 12. Others Image Figure 13. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume Share by Type (2021-2032) Figure 16. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type (2021-2032) Figure 19. Retail Stores Image Figure 20. Online Sales Image Figure 21. Pharmacies Image Figure 22. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume Share by Application (2021-2032) Figure 25. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application (2021-2032) Figure 28. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value (2021-2032) & (US$ Million) Figure 33. North America Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value (2021-2032) & (US$ Million) Figure 39. South America Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Plant-based Cannabidiol (CBD) Nutraceuticals Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Plant-based Cannabidiol (CBD) Nutraceuticals Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules & Softgels
  • CBD Gummies
  • CBD Tinctures
  • Others
Applications
  • Retail Stores
  • Online Sales
  • Pharmacies
Companies covered
  • Medical Marijuana, Inc
  • Isodiol
  • Irwin Naturals
  • Green Roads
  • Garden of Life
  • Foria Wellness
  • Diamond CBD
  • CV Sciences, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value (2021-2032)
  4. 1.2.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume (2021-2032)
  5. 1.2.3 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Plant-based Cannabidiol (CBD) Nutraceuticals Market Dynamics
  1. 2.1 Plant-based Cannabidiol (CBD) Nutraceuticals Industry Trends
  2. 2.2 Plant-based Cannabidiol (CBD) Nutraceuticals Industry Drivers
  3. 2.3 Plant-based Cannabidiol (CBD) Nutraceuticals Industry Opportunities and Challenges
  4. 2.4 Plant-based Cannabidiol (CBD) Nutraceuticals Industry Restraints
3 Plant-based Cannabidiol (CBD) Nutraceuticals Market by Company
  1. 3.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Company Revenue Ranking in 2025
  2. 3.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Revenue by Company (2021-2026)
  3. 3.3 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume by Company (2021-2026)
  4. 3.4 Global Plant-based Cannabidiol (CBD) Nutraceuticals Average Price by Company (2021-2026)
  5. 3.5 Global Plant-based Cannabidiol (CBD) Nutraceuticals Company Ranking (2024-2026)
  6. 3.6 Global Plant-based Cannabidiol (CBD) Nutraceuticals Company Manufacturing Base and Headquarters
  7. 3.7 Global Plant-based Cannabidiol (CBD) Nutraceuticals Company Product Type and Application
  8. 3.8 Global Plant-based Cannabidiol (CBD) Nutraceuticals Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Plant-based Cannabidiol (CBD) Nutraceuticals Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Plant-based Cannabidiol (CBD) Nutraceuticals Market by Type
  1. 4.1 Plant-based Cannabidiol (CBD) Nutraceuticals Type Introduction
  2. 4.1.1 Capsules & Softgels
  3. 4.1.2 CBD Gummies
  4. 4.1.3 CBD Tinctures
  5. 4.1.4 Others
  6. 4.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume by Type
  7. 4.2.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Type
  11. 4.3.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Type (2021-2032)
  13. 4.3.3 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type (2021-2032)
5 Plant-based Cannabidiol (CBD) Nutraceuticals Market by Application
  1. 5.1 Plant-based Cannabidiol (CBD) Nutraceuticals Application Introduction
  2. 5.1.1 Retail Stores
  3. 5.1.2 Online Sales
  4. 5.1.3 Pharmacies
  5. 5.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume by Application
  6. 5.2.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Application
  10. 5.3.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Application (2021-2032)
  12. 5.3.3 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application (2021-2032)
6 Plant-based Cannabidiol (CBD) Nutraceuticals Regional Sales and Value Analysis
  1. 6.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Region (2021-2032)
  3. 6.2.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Region: 2021-2026
  4. 6.2.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Region (2027-2032)
  5. 6.3 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Region (2021-2032)
  7. 6.4.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Region: 2021-2026
  8. 6.4.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Region (2027-2032)
  9. 6.5 Global Plant-based Cannabidiol (CBD) Nutraceuticals Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value (2021-2032)
  12. 6.6.2 North America Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value (2021-2032)
  15. 6.7.2 Europe Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value (2021-2032)
  21. 6.9.2 South America Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Country, 2025 VS 2032
7 Plant-based Cannabidiol (CBD) Nutraceuticals Country-level Sales and Value Analysis
  1. 7.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2021-2032)
  4. 7.3.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2021-2026)
  5. 7.3.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales by Country (2027-2032)
  6. 7.4 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Country (2021-2032)
  7. 7.4.1 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Country (2021-2026)
  8. 7.4.2 Global Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Plant-based Cannabidiol (CBD) Nutraceuticals Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medical Marijuana, Inc
  2. 8.1.1 Medical Marijuana, Inc Company Information
  3. 8.1.2 Medical Marijuana, Inc Business Overview
  4. 8.1.3 Medical Marijuana, Inc Plant-based Cannabidiol (CBD) Nutraceuticals Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Medical Marijuana, Inc Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio
  6. 8.1.5 Medical Marijuana, Inc Recent Developments
  7. 8.2 Isodiol
  8. 8.2.1 Isodiol Company Information
  9. 8.2.2 Isodiol Business Overview
  10. 8.2.3 Isodiol Plant-based Cannabidiol (CBD) Nutraceuticals Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Isodiol Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio
  12. 8.2.5 Isodiol Recent Developments
  13. 8.3 Irwin Naturals
  14. 8.3.1 Irwin Naturals Company Information
  15. 8.3.2 Irwin Naturals Business Overview
  16. 8.3.3 Irwin Naturals Plant-based Cannabidiol (CBD) Nutraceuticals Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Irwin Naturals Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio
  18. 8.3.5 Irwin Naturals Recent Developments
  19. 8.4 Green Roads
  20. 8.4.1 Green Roads Company Information
  21. 8.4.2 Green Roads Business Overview
  22. 8.4.3 Green Roads Plant-based Cannabidiol (CBD) Nutraceuticals Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Green Roads Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio
  24. 8.4.5 Green Roads Recent Developments
  25. 8.5 Garden of Life
  26. 8.5.1 Garden of Life Company Information
  27. 8.5.2 Garden of Life Business Overview
  28. 8.5.3 Garden of Life Plant-based Cannabidiol (CBD) Nutraceuticals Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Garden of Life Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio
  30. 8.5.5 Garden of Life Recent Developments
  31. 8.6 Foria Wellness
  32. 8.6.1 Foria Wellness Company Information
  33. 8.6.2 Foria Wellness Business Overview
  34. 8.6.3 Foria Wellness Plant-based Cannabidiol (CBD) Nutraceuticals Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Foria Wellness Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio
  36. 8.6.5 Foria Wellness Recent Developments
  37. 8.7 Diamond CBD
  38. 8.7.1 Diamond CBD Company Information
  39. 8.7.2 Diamond CBD Business Overview
  40. 8.7.3 Diamond CBD Plant-based Cannabidiol (CBD) Nutraceuticals Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Diamond CBD Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio
  42. 8.7.5 Diamond CBD Recent Developments
  43. 8.8 CV Sciences, Inc.
  44. 8.8.1 CV Sciences, Inc. Company Information
  45. 8.8.2 CV Sciences, Inc. Business Overview
  46. 8.8.3 CV Sciences, Inc. Plant-based Cannabidiol (CBD) Nutraceuticals Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 CV Sciences, Inc. Plant-based Cannabidiol (CBD) Nutraceuticals Product Portfolio
  48. 8.8.5 CV Sciences, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Plant-based Cannabidiol (CBD) Nutraceuticals Value Chain Analysis
  2. 9.1.1 Plant-based Cannabidiol (CBD) Nutraceuticals Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Plant-based Cannabidiol (CBD) Nutraceuticals Sales Mode & Process
  6. 9.2 Plant-based Cannabidiol (CBD) Nutraceuticals Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Plant-based Cannabidiol (CBD) Nutraceuticals Distributors
  9. 9.2.3 Plant-based Cannabidiol (CBD) Nutraceuticals Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst